Titus Wealth Management Lowers Position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Titus Wealth Management decreased its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 4.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,761 shares of the financial services provider’s stock after selling 238 shares during the period. Titus Wealth Management’s holdings in iShares Nasdaq Biotechnology ETF were worth $519,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Meridian Wealth Management LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the first quarter valued at about $36,000. Signaturefd LLC boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 59.2% in the second quarter. Signaturefd LLC now owns 328 shares of the financial services provider’s stock valued at $36,000 after acquiring an additional 122 shares in the last quarter. Oakworth Capital Inc. boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 171.4% in the second quarter. Oakworth Capital Inc. now owns 475 shares of the financial services provider’s stock valued at $52,000 after acquiring an additional 300 shares in the last quarter. Doyle Wealth Management purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at about $52,000. Finally, Family Management Corp purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at about $55,000. 78.95% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ:IBB traded down $0.29 during midday trading on Wednesday, hitting $102.13. The stock had a trading volume of 1,834,472 shares, compared to its average volume of 2,393,738. The stock has a 50 day moving average price of $103.86 and a two-hundred day moving average price of $106.36. iShares Nasdaq Biotechnology ETF has a 1 year low of $89.01 and a 1 year high of $122.97.

The business also recently disclosed a — dividend, which will be paid on Monday, September 30th. Investors of record on Wednesday, September 25th will be paid a $0.0715 dividend. This represents a dividend yield of 0.1%. The ex-dividend date is Tuesday, September 24th.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: What is Put Option Volume?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.